EUROPEAN JOURNAL OF INFLAMMATION Vol. 1, no. 1, 1-8 (2003) DIETARY SUPPLEMENTS FOR ARTHRITIS AND OTHER INFLAMMATORY CONDITIONS: KEY ROLE OF MAST CELLS AND BENEFIT OF COMBINING ANTI-INFLAMMATORY AND PROTEOGLYCAN PRODUCTS* Department of Pharmacology and Experimental TherapeuticsTufts-New England Medical Center, Boston, Ma., USAReceived December 13, 2002 - Accepted March 4, 2003Arthritis is estimated to affect over 30% of all adults and all the available drugs add considerable morbidity and mortality of their own. A recent therapeutic approach targets the mast cells that are currently considered critical in a variety of inflammatory diseases, especially arthritis. Mast cells could be activated by many immune and neural triggers, as well as by many food substances and drugs leading to secretion of numerous vasoactive and inflammatory molecules. Recent studies have shown that mast cells can be inhibited by certain naturally occurring flavonoids, such as quercetin, and the sulfated proteoglycan chondroitin sulfate. Glucosamine and chondroitin are present in many dietary supplements, but neither the source nor the purity of the active substances is listed; moreover, these formulations do not permit sufficient absorption, due to the high molecular weight and negative charge. Moreover, a common source of chondroitin sulfate is cow trachea with the risk of spongioform encephalopathy (mad cow disease). A new series of dietary supplements (Algonot-Plus®) are based on published scientific evidence and combine quercetin, glucosamine sulfate and chondroitin sulfate of high purity in formulations that include kernel olive oil to increase absorption of the inhibitory substances.
Many of the available dietary supplements
widespread problem of arthritis (The coming
contain a multitude of ingredients, some of which
epidemic of arthritis. Time, Dec. 9, 2002) and the
may have biologic effects of their own or may
increasing use of alternative therapy (The Science
interact with other supplements or drugs. A number
of alternative medicine. Newsweek, Dec. 2, 2002).
of these have recently been found inactive in spite
A publication from the US Center for Disease
of anecdotal reports to the contrary; for example,
Control (CDC) indicated that 1/3 of all adults in
Ginkgo has been promoted as a CNS stimulant,
the USA (almost 70 million) suffer from arthritis
but was recently shown to be ineffective in this
or chronic joint pain, up from 1/5 in 1993; the
regard (3). Worse yet, a number of OTC drugs, as
associated annual cost was estimated at $82 billion
well as prescription drugs, such as morphine, can
(Dembner, A. One-third of adults in US have
stimulate mast cell secretion of detrimental
arthritis, according to survey. The Boston Globe,
molecules, especially histamine (4-6). Histamine
Oct. 25: A3, 2002) This number includes both
toxicity can also occur through bacterial histidine
osteoarthritis and rheumatoid arthritis (RA), the
decarboxylase in uncooked tuna burgers (7) or
latter of which is characterized by active joint
cis-Urocanic acid-induced gastrointestinal mast
inflammation. Due to the chronic nature of these
cell release of histamine and other mediators. A
conditions, as well as the serious adverse effects
prime example of dietary supplements that could
of many of the prescription drugs used, increasingly
activate mast cells is those containing Ma Huang
more individuals turns to dietary supplements for
extract that is rich in ephedra alkaloids. Ephedrine
has been associated with sudden cardiac death (8)
Key words: arthritis, inflammation, cytokines, chondroitin sulfate,glucosamine sulfate, quercetin, mast cells, secretionMailing address: T.C. Theoharides, Ph.D., M.D.
Department of Pharmacology and Experimental Therapeutics,
This publication and/or article is for individual use only and may not be further
reproduced without written permission from the copyright holder.
136 Harrison Avenue, Boston, MA 02111, USA
Unauthorized reproduction may result in financial and other penalties
Phone: (617) 636-6866 - Fax: (617) 636-2456
T.C. THEOHARIDES ET AL.
and other vasoactive effects (9) that may derive
been called “piece-meal degranulation” or
“intergranular activation” (43). Mast cells are,therefore, now recognized as key cells in the
development of a number of inflammatory diseases
However, even reviews for clinicians have
(44), including the joints (13, 15).
consistently failed to address mast cells, whichhave recently emerged as key players in arthritis
(10). The evidence of mast cell involvement in
There are no effective clinically available
arthritis recently became indisputable since
mast cell inhibitors, even through disodium
inflammatory arthritis could not develop in mast
cromoglycate, doxandrozole, ketotifen and some
cell deficient mice (11-12). Increasing evidence
histamine-1 receptor antagonists have variable
indicates that mast cells are involved in the
inhibitory effects (45). Aloe vera has been reported
pathophysiology of arthritis (13-23). In fact, stress
to reduce mast cell secretion (46) and mast cell
has been shown to activate mast cells (6) and
infiltration in an inflamed synovial pouch model.
worsen arthritis (24-26). Moreover, corticotropin-
Chondroitin sulfate was recently shown to inhibit
releasing hormone (CRH) secreted immediately
activation of connective tissue mast cells (47).
after stress and its structural analogue urocortin,
Even though many publications reported an
have been shown to be increased in the joints of
inhibitory action of plant flavonoids on mast cells
rheumatoid arthritis patients (27-32). In this context,
(48), this inhibition is not shared by all of the
it is important to note that CRH receptors were
3,000 or so flavonoids known. It was recently
identified on mast cells from rheumatoid arthritis
shown that the inhibition by the flavones kaempferol,
joints (28) and CRH (33), as well as urocortin
q u e r c e t i n a n d m y r i c e t i n d e p e n d s o n t h e
(34), have been shown to activate mast cells.
hydroxylation pattern of their B ring (48). In fact,some flavonoids like morin do not have any
Mast cells are found in most parts of the body
inhibitory activity, while others may actually
and are well known for their involvement in allergic
and anaphylactic reactions (35-36) throughd e g r a n u l a t i o n . H o w e v e r , i n a d d i t i o n t o
immogobulin E and specific antigen, numerous
other non-immune triggers or conditions can activate
supplements containing D-glucosamine have
mast cells; these include anaphylatoxins,
become quite popular for arthritis; most recently,
neuropeptides, bee, ant and jelly fish venum, as
the proteoglycan chondroitin has also been added
well as physical and emotional stress. Upon
(50). However, there are a number of problems
stimulation, over 30 molecules (mediators) are
with the available preparations. Firstly, D-
secreted either preformed from almost 500 secretory
glucosamine and similar sugars normally found in
granules, or made de novo during stimulation.
glycosaminoglycans (GAGs) in joints and elsewhere
These molecules include arachidonic acid products,
could actually promote bacterial adhesion,
biogenic amines, chemoattractants, cytokines,
aggregation and inflammation (51). Glucosamine
growth factors, neuropeptides, proteoglycans and
is made from shellfish chitin and, if it not of high
proteolytic enzymes (37-38). However, the
purity, should be avoided by those allergic to
involvement of mast cells in the pathophysiology
shellfish. Moreover, a common source of chondroitin
of arthritis was missed because they did not appear
sulfate is from cow trachea with the risk, remote as
degranulated. Increasing evidence, however,
it may be, of spongi form encephalopathy (“mad
indicates that biogenic amines (39-40), arachidonic
cow disease”). Most importantly, very little oral
acid products (41), and cytokines (42) are released
chondroitin is absorbed in powder form due to its
from mast cells without degranulation, a process
high molecular weight (150,000 – 1,000,000 daltons)
termed “differential release”. The morphological
and the extensive negative-charge due to sulfation;
appearance of this process is characterized by a
in fact, the more sulfated the molecule, the better
more subtle process of changes within the electron
its beneficial effect, but the worse the absorption.
dense content of the secretory granules and has
Unfortunately, popular magazines and newsletters
Eur. J. Inflamm. Tab. I. Example sof Cartilage rebuilding products. Tab. III. Combination “cartilage rebuilding” and anti-inflammatory products. Nutramax Laboratories, Inc (Edgewood, MD 21040, USA; Algonot, LLC Sarasota, FL 34242, USA; Phone:
800-Algonot or 941-346- 5304; www.algonot.com)
Cosamin DSTM (pills) Let Nature Ease Your Pain ArthroSoft® (soft gel capsules for arthritis) Life Extension (Ft. Landerdale, FL 33309, USA; ArthroSoft® creamfor arthritis ArthriProsystemTM 2 enterically coated fish and ginger oil softgels*Acidity <0.5%; H O<5%; filtered through 0.5 mi-
These products are hypoallergenic, free from artifi-
cial colors or flavors, corn, milk products, preserva-
tives, salt, starch, sugar, wheat or yeast. There are 4
USA and 4 International patents pending. Tab. IV. Other Algonot-Plus® products for inflammatory conditions. Algonot, LLC (Sarasota, FL 34242, USA; Phone: 800-Algonot or 941-346-5304; www.algonot.com) Tab. II. Examples of single anti-inflammatory prod- Let Nature Ease Your Pain® CystoProtek® Desert Harvest (Colorado Springs, CO 80907,
(softgel capsules for interstitial cystitis)
• Aloe Vera dry powder (capsules)
600 mg of freeze- dried aloe vera from whole
NutriCology, Inc. (Hayward, CA 94544, USA; Phone: 510-487-8526) ProstaProtek® Quercetin (pills)
(softgel capsules for chronic prostatitis)
T.C. THEOHARIDES ET AL. Tab. V. Beneficial Effects of Algonot-Plus® Products.
from reputable institutions neglect to mentionthese problems in articles addressed to the consumer.
In particular, less than 5% of chondroitin
sulfate is absorbed intact when administered orally
fava bean source that may cause hemolytic
(52, 53). For instance, after oral administration of
3H- chondroitin sulfate to the rat and dog, 70% of
the radioactivity was absorbed, but the high
molecular weight fraction, which is the one most
Inhibits mast cell and macrophageactivation
useful, was less than 10%. Additionally, if the
⇒ Inhibits histamine and tryptase release
degree of sulfation was high, the absorption was
⇒ Inhibits IL-6, IL-8 and TNF-α release
almost negligible. In another study, oraladministration of a small molecular weight
chondroitin sulfate (16,000 daltons) led to only
13% bioavailability, but when chondroitin sulfate
of about double the size (26,000 daltons) was
used, less than 4% the oral dose administered inrats reached the blood as intact chondroitin sulfate
• Chondroitin sulfate
(54). Other papers found no oral absorption of
⇒ From shark cartilage to avoid the most
chondroitin sulfate and concluded that any protective
effect in the joints after oral administration
Unfortunately, most of the companies that
market products containing glucosamine and/or
⇒ Acts as decoy for microbial adherence
chondroitin do not list the exact amounts, thesource, degree of sulfation or the purity of the
• Glucosamine sulfate
active ingredients (eg. Tab. I). The US Federal
⇒ Building block for cartilage synthesis
Trade Commission (FTC) only ensures that the
⇒ Acts as decoy for microbial adherence
label conforms to certain requirements, such asthat direct therapeutic claims are not made.
• Kernel Olive Oil
Nevertheless, many companies still make unfounded
⇒ Low acidity and special filtration from the
claims and simply change their labels, if pressed
to do so. It is, therefore, very important that health
⇒ Unsaturated fatty acids provide fluidity of
professionals familiarize themselves with which
products are safe, scientifically based and likely
Antioxidants protect against peroxidation
to be of benefit. Some products and their advantages
Polyphenols have anti-inflammatoryactions
or disadvantages are discussed briefly (Tab. I-III). Mechanism of action: cartilage “rebuilding
⇒ Provides greater solubility and absorption
building block for new cartilage, while chondroitinsulfate presumably acts as “ready made” cartilage. * Shark is caught for food and cartilage is
However, chondroitin sulfate has also anti-allergic
and anti-inflammatory properties, primarily through
NSAIDs = non-steroial anti-inflammatory
mast cell inhibition (47). It is particularly critical
that both the glucosamine and chondroitin must behighly sulfated because the sulfated moleculeshave many negative charges that better inhibit thefunction of inflammatory cells (47). Moreover,the sulfated molecules act as decoys attracting
Eur. J. Inflamm.
bacteria and preventing them from adhering to the
Unique benefits of Kernel olive oil
cell surface and causing infection (51). A natural
Kernel olive oil from the island of Crete is of
molecule that has been recently used is the flavonoid
low acidity and water content and undergoes special
quercetin, which has potent antioxidant and anti-
filtration to remove any particular matter. It is
inflammatory properties (48). Quercetin is
considerably richer than olive oil in all the well-
commonly obtained from fava beans that may lead
known antioxidant and other cytoprotective
to hemolytic anemia in G PD deficient persons.
components (58), such as polyphenols, that endow
olive oil with anti-inflammatory and anti-arthritic
Algonot – Plus ® combines “cartilage
actions (59-62) (Tab. V). In fact, olive oil has been
rebuilding” and anti-inflammatory products
reported to have beneficial in rheumatoid arthritis
While glucosamine sulfate may be incorporated
63)” (58, 63), as well as permit concurrent
into new cartilage, chondroitin sulfate appears to
administration of non-steroidal anti-inflammatory
block mast cell activation and the bioflavonoid,
drugs because of its gastric mucosa healing
quercetin, blocks mast cell secretion; the two
properties (58). A study just released also indicated
together lead to better inhibitory results, as published
that adherence to a Mediterranean diet rich in
recently (47, 48). The dietary supplements product
olive oil reduced inflammatory activity in
line, Algonot-Plus® operates under the slogan “Let
rheumatoid arthritis patients (64). Moreover,
Nature Ease Your Pain®”. It includes ArthrotSoft®
supplementation of olive oil with polyphenolic
softgel capsules and a cream. ArthroSoft® contains
compounds, such as those found in kernel olive
glucosamine sulfate from shellfish chitin, together
oil, protected against experimental inflammation
with chondroitin polysulfate obtained from shark
cartilage, instead of the most common source ofcow trachea extract, and quercetin from the saphora
plant to avoid fava beans. ArthroSoft® achieves
Arthritis now appears to affect about 70 million
increased absorption of all three ingredients, due
Americans with a staggering financial burden;
to the fact that the active substances are mixed
similar projections are made for other industrialized
with unprocessed Kernel olive oil. No side effects
countries. The use of alternative therapies for
arthritis has increased dramatically in the last few
The ArthroSoft® cream was developed to be
years with glucosamine and chondroitin being the
used together with ArthroSoft® capsules and would
most commonly used substances. Even though
also be useful for anyone with skin inflammation,
preliminary reports indicate a potential benefit in
especially psoriasis, which worsens by stress (56).
osteoarthritis, potential adverse effects and lack
The ArthroSoft® cream not only contains substantial
of sufficient absorption are not mentioned.
amounts of all the key ingredients found in
M o r e o v e r , t h e p r o b l e m o f o n g o i n g j o i n t
ArthroSoft® capsules, but delivers more of the
inflammation especially prevalent in rheumatoid
same locally due to the presence of kernel olive oil
arthritis is not addressed at all. The new series of
that increases skin absorption. ArthroSoft® can be
Algonot-Plus®, ArthroSoft®, CystoProtek® and
taken along with any treatments for several months
ProstaProtek® under the logo ”Let Nature Ease
your Pain®”, combine glucosamine sulfate, withchondroitin sulfate and quercetin of high purity
and from safe sources in a formulation with kernel
were just made available, CystoProtek® and
olive oil that increases absorption. A companion
ProstaProtek® (Tab. IV) for interstitial cystitis
skin cream also delivers more of the active
and chronic prostatitis, inflammatory conditions
of the urinary bladder and prostate, respectively. ProstaProtek® also contains rutin, the glycoside
form of quercetin that also has anti-arthritisproperties (57). Bielory L. 2002. Complementary and alternative medi-
cine’ population based studies: a growing focus on allergy
T.C. THEOHARIDES ET AL. Schäfer T., A. Riehle, H.-E. Wichmann and J. Ring.
2002. Alternative medicine in allergies - prevalence,
17. de Paulis A., A. Ciccarelli, I. Marinò, G. de Crescenzo,
patterns of use and costs. Allergy 57:694.D. Marinò and G. Marone. 1997. Human synovial mast Solomon P.R., F. Adams, A. Silver, J. Zimmer and R.
cells. II. Heterogeneity of the pharmacologic effects of
De Veaux. 2002. Ginkgo for memory enhancement - A
antiinflammatory and immunosuppressive drugs. Arthritis
randomized controlled trial. JAMA 288:835.Lagunoff D., T.W. Martin and G. Read. 1983. Agents
18. Gotis-Graham I., M.D. Smith, A. Parker and H.P.
that release histamine from mast cells. Annu. Rev.McNeil. 1998. Synovial mast cell responses during clinical
improvement in early rheumatoid arthritis. Ann. Rheum.Barke K.E. and L.B. Hough. 1993. Opiates, mast cells
and histamine release. Life Sci. 53:1391.
19. He S., M.D. Gaca and A.F. Walls. 2001. The activation Theoharides T.C. 2002. Mast cells and stress - a
of synovial mast cells: modulation of histamine release
psychoneuroimmunological perspective. J. Clin.
by tryptase and chymase and their inhibitors. Eur. J.Becker K., K. Southwick, J. Reardon, R. Berg and
20. Olsson N., A.K. Ulfgre and G. Nilsson. 2001. J.N. MacCormack. 2001. Histamine poisoning associated
Demonstration of mast cell chemotactic activity in synovial
with eating tuna burgers. JAMA 285:1327.
fluid from rheumatoid patients. Ann. Rheum. Dis. 60:187.Theoharides T.C. 1997. Sudden death of a healthy
21. Ceponis A., Y.T. Konttinen, M. Takagi, J.W. Xu, T.
college student related to ephedrine toxicity from a ma
Sorsa, M. Matucci-Cerinic, S. Santavirta, H.C. Bankl
huang-containing drink. J. Clin. Psychopharmacol. 17:437.and P. Valent. 1998. Expression of stem cell factor Samenuk D., M.S. Link, M.K. Homoud, R. Contreras,
(SCF) and SCF receptor (c-kit) in synovial membrane in
T.C. Theoharides, P.J. Wang and N. III. Estes. 2002.
arthritis: correlation with synovial mast cell hyperplasia
Adverse cardiovascular events temporally associated
and inflammation. J. Rheumatol. 25:2304.
with ma huang, an herbal source of ephedrine. Mayo
22. Bridges A.J., D.G. Malone, J. Jicinsky, M. Chen, P. Ory, W. Engber and F.M. Graziano. 1991. Human
10. Bauer B.A. 2000. Herbal therapy: what a clinician needs
synovial mast cell involvement in rheumatoid arthritis
to know to counsel patients effectively. Mayo Clin.
and osteoarthritis. Relationship to disease type, clinical
activity, and antirheumatic therapy. Arthritis Rheum.
11. Huang M., J. Berry, K. Kandere, M. Lytinas, K. Karalis and T.C. Theoharides. 2002. Mast cell deficient
23. Kiener H.P., M. Baghestanian, M. Dominkus, S.
W/Wv mice lack stress-induced increase in serum IL-6
Walchshofer, M. Ghannadan, M. Willheim, C. Sillaber,
levels, as well as in peripheral CRH and vascular
W.B. Graninger, J.S. Smolen and P. Valent. 1998.
permeability, a model of rheumatoid arthritis. Int. J.
Expression of the C5a receptor (CD88) on synovial mast
cells in patients with rheumatoid arthritis. Arthritis Rheum.
12. Lee D.M., D.S. Friend, M.F. Gurish, C. Benoist, D. Mathis and M.B. Brenner. 2002. Mast cells: a cellular
24. Thomason B.T., P.J. Brantley, G.N. Jones, H.R. Dyer,
link between autoantibodies and inflammatory arthritis. and J.L. Morris. 1992. The relation between stress and
disease activity in rheumatoid arthritis. J. Behav. Med.
13. Wasserman S.I. 1984. The mast cell and synovial
inflammation. Arthritis Rheum. 27:841.
25. J o h n s o n E . O . a n d M . M o u t s o p o u l o s . 1 9 9 2 .
14. Crisp A.J., C.M. Champan, S.E. Kirkham, A.L. Schiller
Neuroimmunological axis and rheumatic diseases. Eur.and S.M. Keane. 1984. Articular mastocytosis in
rheumatoid arthritis. Arthritis Rheum. 27:845.
26. Herrmann M., J. Scholmerich and R.H. Straub. 2000.
15. Tetlow L.C. and D.E. Woolley. 1995. Distribution,
Stress and rheumatic diseases. Rheum. Dis. Clin. North
activation and tryptase/chymase phenotype of mast cells
in the rheumatoid lesion. Ann. Rheum. Dis. 54:549.
27. Crofford L.J., H. Sano, K. Karalis, T.C. Friedman,
16. de Paulis A., I. Marino, A. Ciccarelli, G. de Crescenzo, H.R. Epps, E.F. Remmers, P. Mathern, G.P. Chrousos M. Concardi, L. Verga, E. Arbustini and G. Marone. and R.L. Wilder. 1993. Corticotropin-releasing hormone
1996. Human synovial mast cells. I. Utrastructural in
in synovial fluids and tissues of patients with rheumatoid
situ and in vitro immunologic characterization. Arthritis
arthritis and osteoarthritis. J. Immunol. 151:1.Eur. J. Inflamm.
28. McEvoy A.N., B. Bresnihan, O. FitzGerald and E.P.
41. Benyon R., C. Robinson and M.K. Church. 1989. Murphy. 2001. Corticotropin-releasing hormone signaling
Differential release of histamine and eicosanoids from
in synovial tissue from patients with early inflammatory
human skin mast cells activated by IgE-dependent and
arthritis is mediated by the type 1α corticotropin-releasing
non-immunological stimuli. Br. J. Pharmacol. 97:898.
hormone receptor. Arthritis Rheum. 44:1761.
42. Gagari E., M. Tsai, C.S. Lantz, L.G. Fox and S.J.
29. Uzuki M., H. Sasano, Y. Muramatsu, K. Totsune, K. Galli. 1997. Differential release of mast cell interleukin- Takahashi, Y. Oki, K. Iino and T. Sawai. 2001. Urocortin
in the synovial tissue of patients with rheumatoid arthritis.
43. Letourneau R., X. Pang, G.R. Sant and T.C. Theoharides. 1996. Intragranular activation of bladder
30. Kohno M., Y. Kawahito, Y. Tsubouchi, A. Hashiramoto,
mast cells and their association with nerve processes in
R. Yamada, K.I. Inoue, Y. Kusaka, T. Kubo, I.J.
interstitial cystitis. Br. J. Urol. 77:41.Elenkov, G.P. Chrousos, M. Kondo and H. Sano.
44. T h e o h a r i d e s T . C . 1 9 9 6 . T h e m a s t c e l l : a
2001. Urocortin expression in synovium of patients with
neuroimmunoendocrine master player. Int. J. Tissue React.
rheumatoid arthritis and osteoarthritis: relation to
inflammatory activity. J. Clin. Endocrinol. Metab. 86:4344.
45. Bielory L., D. Kempuraj and T.C. Theoharides. 2002.
31. Nishioka T., H. Kurokawa, R. Takao, Y. Kumon, K.
Topical immunopharmacology of ocular allergies. Curr.Nishiya and K. Hashimoto. 1996. Differential changes Opin. Allergy Clin. Immunol. 2:435.
of corticotropin releasing hormone (CRH) concentrations
46. Ro J.Y., B.C. Lee, J.Y. Kim, Y.J. Chung, M.H. Chung,
in plasma and synovial fluids of patients with rheumatoid
S.K. Lee, T.H. Jo, K.H. Kim and Y.I. Park. 2000.
arthritis (RA). Endocr. J. 43:241.
Inhibitory mechanism of aloe single component (alprogen)
32. Crofford L.J., H. Sano, K. Karalis, E.A. Webster,
on mediator release in guinea pig lung mast cells activated
T.C. Friedman, G.P. Chrousos and R.L. Wilder. 1995.
with specific antigen-antibody reactions. J. Pharmacol.
Local expression of corticotropin-releasing hormone in
inflammatory arthritis. Ann. N. Y. Acad. Sci. 771:459.
47. Theoharides T.C., P. Patra, W. Boucher, R. Letourneau,
33. Theoharides T.C., L.K. Singh, W. Boucher, X. Pang, D. Kempuraj, G. Chiang, S. Jeudy, L. Hesse and A. R. Letourneau, E. Webster and G. Chrousos. 1998. Athanasiou. 2000. Chondroitin sulfate inhibits connective
Corticotropin-releasing hormone induces skin mast cell
tissue mast cells. Br. J. Pharmacol. 131:10139.
degranulation and increased vascular permeability, a
48. Middleton E., Jr., C. Kandaswami and T.C.
possible explanation for its pro-inflammatory effects. Theoharides. 2000. The effects of plant flavonoids on
mammalian cells:Implications for inflammation, heart
34. Singh L.K., W. Boucher, X. Pang, R. Letourneau, D.
disease and cancer. Pharmacol. Res. 52:673.Seretakis, M. Green and T.C. Theoharides. 1999.
49. Theoharides T.C., M. Alexandrakis, D. Kempuraj
Potent mast cell degranulation and vascular permeability
and M. Lytinas. 2001. Anti-inflammatory actions of
triggered by urocortin through activation of CRH receptors.
flavonoids and structural requirements for new design. J. Pharmacol. Exp. Ther. 288:1349.Int. J. Immunopath. Pharmacol. 14:119.
35. Galli S.J. 1993. New concepts about the mast cell. N.
50. McAlindon T.E., M.P. LaValley, J.P. Gulin and D.T. Felson. 2000. Glucosamine and chondroitin for treatment
36. Rosenwasser L.J. and J.A. Boyce. 2003. Mast cells:
Beyond IgE. J. Allergy Clin. Immunol. 111:24.
51. Duensing T.D., J.S. Wing and J.P.M. vanPutten. 1999.
37. Schwartz L.B. 1987. Mediators of human mast cells and
Sulfated polysaccharide-directed recruitment of
human mast cell subsets. Ann. Allergy 58:226.
mammalian host proteins:a novel strategy in microbial
38. Kobayashi H., T. Ishizuka and Y. Okayama. 2000.
pathogenesis. Infect. Immun. 67:4463.
Human mast cells and basophils as sources of cytokines.
52. Conte A., L. Palmieri, D. Segnini and G. Ronca. 1991.
Metabolic fate of partially depolymerized chondroitin sulfate
39. Theoharides T.C., P.K. Bondy, N.D. Tsakalos and
administered to the rat. Drugs Exp. Clin. Res. 17:27.P.W. Askenase. 1982. Differential release of serotonin
53. Conte A., N. Volpi, L. Palmieri, I. Bahous and G.
and histamine from mast cells. Nature 297:229.Ronca. 1995. Biochemical and pharmacokinetic aspects
40. Dvorak A.M., D.W. Macglashan, Jr., E.S. Morgan
o f o r a l t r e a t m e n t w i t h c h o n d r o i t i n s u l f a t e . and L.M. Lichtenstein. 1996. Vesicular transport of
histamine in stimulated human basophils. Blood 88:4090.
54. Conte A., M. de Bernardi, L. Palmieri, P. Lualdi, G. T.C. THEOHARIDES ET AL. Mautone and G. Ronca. 1991. Metabolic fate of
olive oil diet. Inflamm. Res. 50:102.
e x o g e n o u s c h o n d r o i t i n s u l f a t e i n m a n .
60. Linos A., V.G. Kaklamani, E. Kaklamani, Y. Koumantaki, E. Giziaki, S. Papazoglou and C.S.
55. Baici A., D. Horler, B. Moser, H.O. Hofer, K. Fehr Mantzoros. 1999. Dietary factors in relation to rheumatoid a n d F . J . W a g e n h a u s e r . 1 9 9 2 . A n a l y s i s o f
arthritis: a role for olive oil and cooked vegetables? Am.
glycosaminoglycans in human serum after oral
administration of chondroitin sulfate. Rheumatol. Int.
61. Linos A., E. Kaklamanis, A. Kontomerkos, Y. Koumantaki, S. Gazi, G. Vaiopoulos, G.C. Tsokos
56. Katsarou-Katsari A., A. Filippou and T.C. Theoharides. and P. Kaklamanis. 1991. The effect of olive oil and
1999. Effect of stress and other psychological factors on
fish consumption on rheumatoid arthritis - a case control
the pathophysiology and treatment of dermatoses. Int. J.
study. Scand. J. Rheumatol. 20:419.
62. Kremer J.M., D.A. Lawrence, W. Jubiz, R. DiGiacomo,
57. Ostrakhovitch E.A. and I.B. Afanas’ev. 2001. Oxidative R. Rynes, L.E. Bartholomew and M. Sherman. 1990.
stress in rheumatoid arthritis leukocytes: suppression by
Dietary fish oil and olive oil supplementation in patients
rutin and other antioxidants and chelators. Biochem.
with rheumatoid arthritis. Clinical and immunologic
58. Alarcon de la Lastra C., M.D. Barranco, V. Motilva
63. Kjeldsen-Kragh J. 2003. Mediterranean diet intervention and J.M. Herrerias. 2001. Mediterranean diet and health:
in rheumatoid arthritis. Ann. Rheum. Dis. 62:193.
biological importance of olive oil. Curr. Pharm. Des.
64. Skoldstam L., L. Hagfors and G. Johansson. 2003. An
experimental study of a Mediterranean diet intervention
59. Martinez-Dominuez E., R. de la Puerta and V. Ruiz-
for patients with rheumatoid arthritis. Ann. Rheum. Dis.Gutierrez. 2001. Protective effects upon experimental
inflammation models of a polyphenol-supplemented virgin
Sede Operativa: 48121 Ravenna Via Baccarini,66-68 ; tel . 0544 39534; fax 0544 245471; cell.o SMS: 329 2374440 ctacli.Ravenna@racine.ra.it ; www.ctacli.ra.it CIPRO,un mondo da scoprire 18-25 Ottobre 2011 - 8 giorni/7 notti Viaggio di Turismo Culturale e Religioso guidato da don Edero Onofri Un'isola al confine tra Oriente e Occidente, una terra che ha osp
Ú T M U T A T Ó HÁZIPATIKA ÖSSZEÁLLÍTÁSÁHOZ 1. Fájdalom-, lázcsillapítók 1. Paracetamol és kombínációi Általános ismertetés: a parecatamol fájdalom- és lázcsillapító hatóanyag, gyulladáscsökkentő hatása azonban – szemben az ún. nemszteroid gyulladásgátlókkal - gyakorlati szempontból jelentéktelen. Javallatok: paracetamol tartalmú gyógysze